What does CUSIP 137404109 represent in this 13F holders report?

CUSIP 137404109 is the security identifier for CADL - Candel Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held CADL - Candel Therapeutics, Inc. - Common Stock in Q3 2025?

81 institutional investors reported CADL - Candel Therapeutics, Inc. - Common Stock for Q3 2025. Use the holders table for investor-level position and value details.

Candel Therapeutics, Inc. - Common Stock (CADL)

CUSIP: 137404109

Q3 2025 13F Holders as of 30 Sep 2025

Security type / class: Equity / Common Stock
Total 13F shares: 22,668,478
Total 13F value: $115,621,483
Share change: -373,355
Put/Call ratio: 41%
SEC-reported price per share: $5.10
Number of holders: 81
Value change: -$1,871,335
Number of buys: 40
Number of sells: 36
Shares outstanding: 73,256,045

Security key

137404109

Report period

Q3 2025

Institutions

Top holders

CADL full security history Ownership snapshot Full 13F holder table Candel Therapeutics, Inc. SEC filings Candel Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CADL - Candel Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

FMR LLC

Disclosed value leader

FMR LLC

Comparable rows

15/15

Latest evidence

30 Jun 2025

13F 13D/G Lead comparable stake: 15% 13D/G row: FMR LLC Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 15%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.

Comparable ownership Top 5

FMR LLC 15%

Paul B. Manning 7.9%

ACORN BIOVENTURES, L.P. 5.2%

BAKER BROS. ADVISORS LP 5%

ACORN CAPITAL ADVISORS, LLC 3.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
FMR LLC	13F 13D/G Company 13F 13D/G	15% from 13D/G	$41,661,181 8,233,435 shares	—	30 Jun 2025
Paul B. Manning	13D/G 13D/G	7.9%	$29,997,375 5,790,999 shares	$0	16 Dec 2024
ACORN BIOVENTURES, L.P.	13D/G Anders Hove 13D/G	5.2%	$14,115,428 2,580,517 shares	$0	25 Jun 2025
BAKER BROS. ADVISORS LP	13D/G 13F Company 13D/G 13F	5%	$11,882,723 2,455,108 shares	-$2,550,075	31 Mar 2025
ACORN CAPITAL ADVISORS, LLC	13F Company 13F	3.5%	$13,057,416 2,580,517 shares	—	30 Jun 2025
BlackRock, Inc.	13F Company 13F	3.1%	$11,647,336 2,301,845 shares	—	30 Jun 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

22,668,478

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders

Q3 2025 holders

Holder diff

Investor	Q2 2025 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2025 value	Q3 2025 value	Value change	Value Chg %